New patent for Neurocrine drug INGREZZA
Annual Drug Patent Expirations for INGREZZA Ingrezza is a drug marketed by Neurocrine and is included in one NDA. It is available from one supplier. There are fifteen patents protecting…
The post New patent for Neurocrine drug INGREZZA appeared first o…